H. Gundacker

发表

A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team.

S. Hammer, D. Katzenstein, M. Hughes, 1996, The New England journal of medicine.

novel biologic clusters for risk classification and outcome prediction Gene expression profiling of adult acute myeloid leukemia identifies

H. Gundacker, J. Radich, D. Ankerst, 2008 .

Cyclophosphamide followed by fludarabine for untreated chronic lymphocytic leukemia: a phase II SWOG TRIAL 9706

H. Gundacker, F. Appelbaum, K. Foon, 2005, Leukemia.

Effect of complete remission and responses less than complete remission on survival in acute myeloid leukemia: a combined Eastern Cooperative Oncology Group, Southwest Oncology Group, and M. D. Anderson Cancer Center Study.

H. Gundacker, E. Estey, F. Appelbaum, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase 2 study of lenalidomide monotherapy in patients with deletion 5q acute myeloid leukemia: Southwest Oncology Group Study S0605.

H. Gundacker, F. Appelbaum, C. Willman, 2011, Blood.

Risk Factors for Incidence of Sexually Transmitted Infections Among Women in a Human Immunodeficiency Virus Chemoprevention Trial: VOICE (MTN-003)

H. Gundacker, B. Richardson, B. G. Mirembe, 2017, Sexually transmitted diseases.

Acceptability of an extended duration vaginal ring for HIV prevention and interest in a multi-purpose ring

H. Gundacker, A. van der Straten, J. Piper, 2022, PloS one.

Impact of tamoxifen on the pharmacokinetics and endocrine effects of the aromatase inhibitor letrozole in postmenopausal women with breast cancer.

H. Gundacker, M. Dowsett, D. Miles, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Sequential phase II Southwest Oncology Group studies (S0112 and S0301) of daunorubicin and cytarabine by continuous infusion, without and with ciclosporin, in older patients with previously untreated acute myeloid leukaemia

H. Gundacker, M. Slovak, F. Appelbaum, 2010, British journal of haematology.

Four different regimens of farnesyltransferase inhibitor tipifarnib in older, untreated acute myeloid leukemia patients: North American Intergroup Phase II study SWOG S0432.

H. Gundacker, R. Larson, M. Slovak, 2014, Leukemia research.

A retrospective study of 69 patients with t(6;9)(p23;q34) AML emphasizes the need for a prospective, multicenter initiative for rare ‘poor prognosis’ myeloid malignancies

C. Bloomfield, H. Gundacker, S. Raimondi, 2006, Leukemia.

Brief report Connective tissue growth factor (CTGF) expression and outcome in adult patients with acute lymphoblastic leukemia

H. Gundacker, J. Radich, S. Heimfeld, 2007 .

A Phase II Study of Lenalidomide for Previously Untreated Deletion (del) 5q Acute Myeloid Leukemia (AML) Patients Age 60 or Older Who Are Not Candidates for Remission Induction Chemotherapy (Southwest Oncology Group Study S0605)

H. Gundacker, F. Appelbaum, C. Willman, 2010 .

Phase 1 Safety and Pharmacokinetics Study of MK-2048/Vicriviroc (MK-4176)/MK-2048A Intravaginal Rings

Ashley J. Mayo, H. Gundacker, J. Bauermeister, 2018, Clinical Infectious Diseases.

The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team.

S. Hammer, D. Katzenstein, M. Hughes, 1996, The New England journal of medicine.

Phase 2a Safety, Pharmacokinetics, and Acceptability of Dapivirine Vaginal Rings in US Postmenopausal Women

H. Gundacker, A. van der Straten, C. Hendrix, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Age and acute myeloid leukemia.

H. Gundacker, M. Slovak, F. Appelbaum, 2006, Blood.

Gene expression profiling of adult acute myeloid leukemia identifies novel biologic clusters for risk classification and outcome prediction.

Erik Andries, Donna P Ankerst, Huining Kang, 2006, Blood.

Phase 1 pharmacokinetics and safety study of extended duration dapivirine vaginal rings in the United States

H. Gundacker, A. van der Straten, Patrick Spence, 2021, Journal of the International AIDS Society.

Impact of trisomy 8 (+8) on clinical presentation, treatment response, and survival in acute myeloid leukemia: a Southwest Oncology Group study.

H. Gundacker, M. Slovak, F. Appelbaum, 2002, Blood.

Within-subject variation in CD4 lymphocyte count in asymptomatic human immunodeficiency virus infection: implications for patient monitoring.

D S Stein, M D Hughes, M. Hughes, 1994, The Journal of infectious diseases.

Southwest Oncology Group Study S0530: a phase 2 trial of clofarabine and cytarabine for relapsed or refractory acute lymphocytic leukaemia

H. Gundacker, J. Radich, M. Slovak, 2010, British journal of haematology.

Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trial.

H. Gundacker, H. Lenz, M. Press, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Assessment of HER 2 gene ampli fi cation in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116 / SWOG 9008 clinical trial

H. Gundacker, H. Lenz, M. Press, 2013 .

Effects of letrozole as primary medical therapy on in situ oestrogen synthesis and endogenous oestrogen levels within the breast

H. Gundacker, J. Dixon, W. Miller, 1998 .

TO: ALL SWOG MEMBER, CCOP AND AFFILIATE MEDICAL ONCOLOGISTS FROM: SWOG Operations Office RE: IND Safety Reports for IMC-A12 MEMORANDUM

H. Gundacker, C. Tangen, C. Rankin, 2011 .

Connective tissue growth factor (CTGF) expression and outcome in adult patients with acute lymphoblastic leukemia.

H. Gundacker, J. Radich, S. Heimfeld, 2007, Blood.

Age and the nature of acute myeloid leukemia.

H. Gundacker, F. Appelbaum, 2004, Annals of hematology.

Acceptability of a Dapivirine/Placebo Gel Administered Rectally to HIV-1 Seronegative Adults (MTN-026)

H. Gundacker, J. Bauermeister, J. Piper, 2021, AIDS and Behavior.

Brief Report: Routine Use of Oral PrEP in a Phase 2 Rectal Microbicide Study of Tenofovir Reduced-Glycerin 1% Gel (MTN-017).

H. Gundacker, T. Holtz, A. Carballo-Diéguez, 2019, Journal of acquired immune deficiency syndromes.

A Randomized, Double Blind, Placebo-Controlled, Phase 1 Safety and Pharmacokinetic Study of Dapivirine Gel (0.05%) Administered Rectally to HIV-1 Seronegative Adults (MTN-026).

Clara P Domínguez-Islas, H. Gundacker, J. Bauermeister, 2021, AIDS research and human retroviruses.

Prognostic implications of additional chromosome abnormalities among patients with de novo acute promyelocytic leukemia with t(15;17)

H. Gundacker, M. Slovak, F. Appelbaum, 2012, Medical Oncology.

Evaluation of Gemcitabine in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: A Southwest Oncology Group Phase II Study

H. Gundacker, W. Samlowski, J. Ensley, 2004, Investigational New Drugs.

Prevalence and determinants of anal human papillomavirus infection in men who have sex with men and transgender women

Ross D. Cranston, H. Gundacker, A. Carballo-Diéguez, 2018, International journal of STD & AIDS.

Zidovudine side effects as reported by black, Hispanic, and white/non-Hispanic patients with early HIV disease: combined analysis of two multicenter placebo-controlled trials.

M. Hughes, H. Gundacker, P. Volberding, 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

adult patients with acute lymphoblastic leukemia Connective tissue growth factor (CTGF) expression and outcome in

H. Gundacker, J. Radich, S. Heimfeld, 2013 .

The clinical spectrum of adult acute myeloid leukaemia associated with core binding factor translocations

H. Gundacker, E. Estey, M. Slovak, 2006, British journal of haematology.

Phase II Studies of Different Schedules and Doses of the Farnesyl Transferase Inhibitor Tipifarnib (R115777, Zarnestra, NSC-702818) for Patients of Age 70 or Older with Previously Untreated Acute Myeloid Leukemia (AML): A North American Intergroup Study (S0432).

H. Gundacker, R. Larson, M. Slovak, 2007 .

novel biologic clusters for risk classification and outcome prediction Gene expression profiling of adult acute myeloid leukemia identifies

H. Gundacker, J. Radich, D. Ankerst, 2008 .

Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trial.

H. Gundacker, H. Lenz, M. Press, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.